Assort Health, an AI platform for specialty-specific patient call management, secured $26 million in a funding round co-led by First Round Capital and Chemistry, with Quiet Capital and existing investors like Four Acres, Tau Ventures, and prominent angel investors from Athena Health, Flatiron Health, and others. The funds will fuel Assort Health’s mission to streamline healthcare access by reducing long hold times and scheduling errors.

Founded by Jon Wang and Jeff Liu, Assort Health leverages voice AI to address inefficiencies in healthcare call centers, where patients often wait up to 35 minutes to book appointments, and 20 million are misassigned annually. The platform enables 24/7 access, cutting hold times dramatically—Peninsula Orthopaedic Associates reduced wait times from 11 minutes to one minute within 30 days. Since its 2023 launch, Assort Health has managed millions of calls, serving hundreds of thousands of patients with a 4.6/5 satisfaction rating and driving 8x revenue growth since Q4 2024.

“Assort Health’s AI navigates complex scheduling with precision, freeing clinicians to focus on care,” said Bill Trenchard of First Round Capital. The company’s proprietary technology and safety measures are setting a new standard for efficient, accessible healthcare, with plans to further innovate patient-provider interactions.

“Voice AI is transforming how patients access care,” said Kristina Shen of Chemistry. “Assort Health is leading the charge, modernizing healthcare systems with unmatched speed and accuracy.”